Description
Phase
Phase 1 - a new treatment that has not been tested, and researchers are looking for the best way to administer the treatment and how much can be given safely. Phase I trials are usually offered only to patients with advanced disease who would not be helped by other known treatments. Some patients are helped by these treatments, although in this early stage physicians don’t really know if the treatment will be effective.Inclusion and Exclusion Criteria
Please contact Daisy Sosa to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- Pfizer Investigational Site, Los Angeles, California, 90033
- Keck Hospital of USC, Los Angeles, California, 90033
- Lac & Usc Medical Center, Los Angeles, California, 90033
- USC/Norris Comprehensive Cancer Center, Los Angeles, California, 90033
- Keck Hospital of USC, Los Angeles, California, 90033
- Lac & Usc Medical Center, Los Angeles, California, 90033
-
Colorado
- University of Colorado Denver CTO (CTRC), Aurora, Colorado, 88045
- Pfizer Investigational Site, Aurora, Colorado, 88045
- Pfizer Investigational Site, Denver, Colorado, 80045
- Anschutz Cancer Pavilion, Aurora, Colorado, 80045
- University of Colorado Hospital, Denver, Colorado, 80045
-
Washington
- University of Washington Medical Center, Seattle, Washington, 98195
- Pfizer Investigational Site, Seattle, Washington, 98109
- Seattle Cancer Care Alliance (Drug Shipment Address), Seattle, Washington, 98109
- Seattle Cancer Care Alliance, Seattle, Washington, 98109
Powered by
SC CTSI